These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


280 related items for PubMed ID: 12869391

  • 21. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
    Liu Z, Chen JM, Huang H, Kuznicki M, Zheng S, Sun W, Quan N, Wang L, Yang H, Guo HM, Li J, Zhuang J, Zhu P.
    Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
    [Abstract] [Full Text] [Related]

  • 22. Chronic angina: new medical options for treatment.
    McCullough PA.
    Rev Cardiovasc Med; 2005 Mar; 6(3):152-61. PubMed ID: 16195688
    [Abstract] [Full Text] [Related]

  • 23. Ranolazine. A metabolic modulator for the treatment of chronic stable angina.
    Anderson JR, Nawarskas JJ.
    Cardiol Rev; 2005 Mar; 13(4):202-10. PubMed ID: 15949056
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure.
    Rupp H, Zarain-Herzberg A, Maisch B.
    Herz; 2002 Nov; 27(7):621-36. PubMed ID: 12439634
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Efficiency of trimetazidine treatment of experimental ischemic heart disease in age aspect].
    Kukes VG, Zhernakova NI, Gorbach TV, Romashchenko OV, Rumbesht VV.
    Eksp Klin Farmakol; 2013 Nov; 76(2):9-12. PubMed ID: 23631276
    [Abstract] [Full Text] [Related]

  • 30. Cardiac mitochondrial alterations induced by insulin deficiency and hyperinsulinaemia in rats: targeting membrane homeostasis with trimetazidine.
    Ovide-Bordeaux S, Bescond-Jacquet A, Grynberg A.
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1061-70. PubMed ID: 16445572
    [Abstract] [Full Text] [Related]

  • 31. [Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism].
    Lopaschuk GD.
    Presse Med; 1998 Dec 12; 27(39):2100-4. PubMed ID: 9893703
    [Abstract] [Full Text] [Related]

  • 32. Ranolazine inhibits an oxidative stress-induced increase in myocyte sodium and calcium loading during simulated-demand ischemia.
    Zhang XQ, Yamada S, Barry WH.
    J Cardiovasc Pharmacol; 2008 May 12; 51(5):443-9. PubMed ID: 18398379
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Expression and purification of His-tagged rat mitochondrial 3-ketoacyl-CoA thiolase wild-type and His352 mutant proteins.
    Zeng J, Li D.
    Protein Expr Purif; 2004 Jun 12; 35(2):320-6. PubMed ID: 15135409
    [Abstract] [Full Text] [Related]

  • 35. Trimetazidine-induced enhancement of myocardial glucose utilization in normal and ischemic myocardial tissue: an evaluation by positron emission tomography.
    Mody FV, Singh BN, Mohiuddin IH, Coyle KB, Buxton DB, Hansen HW, Sumida R, Schelbert HR.
    Am J Cardiol; 1998 Sep 03; 82(5A):42K-49K. PubMed ID: 9737485
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
    Lee L, Horowitz J, Frenneaux M.
    Eur Heart J; 2004 Apr 03; 25(8):634-41. PubMed ID: 15084367
    [Abstract] [Full Text] [Related]

  • 40. Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine.
    Stanley WC, Marzilli M.
    Fundam Clin Pharmacol; 2003 Apr 03; 17(2):133-45. PubMed ID: 12667223
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.